ENYO Pharma

Eternygen

This biopharmaceutical company develops small molecule inhibitors targeting metabolic diseases, such as fatty liver and diabetes, for patients needing novel medical treatments.

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Allena

This biopharmaceutical company develops oral enzyme therapeutics for patients with rare and severe metabolic and kidney disorders, such as hyperoxaluria.

Enemsa Pharma

This company develops small-molecule neuroprotective therapies and combination drugs to treat patients with rare neurodegenerative and cardiopulmonary diseases.

Calluna Pharma

This clinical-stage company develops monoclonal antibodies to treat inflammatory and fibrotic diseases for patients with conditions like idiopathic pulmonary fibrosis and chronic kidney disease.

Nionyx Bio

The company develops adeno-associated virus gene therapies for patients with genetic kidney diseases.

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.

Purespring Therapeutics

This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.